Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00NBJ
|
|||
| Drug Name |
Remetinostat
|
|||
| Synonyms |
UNII-37NT056AT4; 946150-57-8; Methylparaben suberohydroxamic acid phenyl ester; 37NT056AT4; Remetinostat [USAN]; Remetinostat (USAN/INN); CHEMBL3707219; SCHEMBL12682510; DTXSID20647779; NSC748492; Benzoic acid, 4-((8-(hydroxyamino)-1,8-dioxooctyl)oxy)-, methyl ester; NSC-748492; D10977; methyl 4-[8-(hydroxyamino)-8-oxooctanoyl]oxybenzoate; Methyl 4-{[8-(hydroxyamino)-8-oxooctanoyl]oxy}benzoate; Benzoic acid,8-dioxooctyl]oxy]-, methyl ester (MP-shape)
Click to Show/Hide
|
|||
| Indication | Basal cell carcinoma [ICD-11: 2C32; ICD-10: C44] | Phase 2 | [1] | |
| Cutaneous T-cell lymphoma [ICD-11: 2B01; ICD-10: C84.8; ICD-9: 202.1, 202.2] | Phase 2 | [1], [2] | ||
| Company |
Medivir Huddinge, Sweden
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H21NO6
|
|||
| Canonical SMILES |
COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO
|
|||
| InChI |
1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18)
|
|||
| InChIKey |
XDZAHHULFQIBFE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 946150-57-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase (HDAC) | Target Info | Inhibitor | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.